NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”
In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes
Komen Foundation Shifts Emphasis To Underserved
Clinton Budget For NIH “Disappointing,” AACR executive Director Says
ACS Expresses Concern About “Fletcher Report” On Mammography
FDA Ceases Exclusion Of Women From Early Drug Studies
ACS Encourages Grant Applications In All Aspects Of Pain Control
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”









